Stay updated on AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-25T14:42:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding/status notice about government operations has been removed from the page; the rest of the study details and site links remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:25:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    No substantive changes to the study data are visible; the core details (title, conditions, endpoints, eligibility criteria, and locations) appear unchanged. Any differences seem to be minor formatting or layout adjustments only.
    Difference
    0.4%
    Check dated 2025-10-27T21:04:29.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:15:38.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version label updated from v3.0.2 to v3.1.0; core content and other critical data remain unchanged.
    Difference
    0.1%
    Check dated 2025-09-29T04:46:08.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top link was removed. No changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T22:27:44.000Z thumbnail image

Stay in the know with updates to AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.